Back to search
De Novo Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which De Novo Mutation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which De Novo Mutation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this Phase I, multicenter, clinical trial is to evaluate the safety of AG-120 and AG-221 when given in combination with standard AML induction an…
The current standard of patients with de novo metastatic hormone sensitive prostate cancer (mHSPC) is to offer androgen deprivation therapy (ADT) with androgen…